1 Report Business Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Premenstrual Dysphoric Disorder (PMDD) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 1.2.2 Table Product 1.2.3 Inject Product 1.2.4 Others 1.3 Market by Application 1.3.1 Global Premenstrual Dysphoric Disorder (PMDD) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 1.3.2 Hospital 1.3.3 Clinic 1.3.4 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Premenstrual Dysphoric Disorder (PMDD) Market Perspective (2017-2028) 2.2 Premenstrual Dysphoric Disorder (PMDD) Growth Trends by Region 2.2.1 Premenstrual Dysphoric Disorder (PMDD) Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 Premenstrual Dysphoric Disorder (PMDD) Historic Market Size by Region (2017-2022) 2.2.3 Premenstrual Dysphoric Disorder (PMDD) Forecasted Market Size by Region (2023-2028) 2.3 Premenstrual Dysphoric Disorder (PMDD) Market Dynamics 2.3.1 Premenstrual Dysphoric Disorder (PMDD) Industry Trends 2.3.2 Premenstrual Dysphoric Disorder (PMDD) Market Drivers 2.3.3 Premenstrual Dysphoric Disorder (PMDD) Market Challenges 2.3.4 Premenstrual Dysphoric Disorder (PMDD) Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Premenstrual Dysphoric Disorder (PMDD) Players by Revenue 3.1.1 Global Top Premenstrual Dysphoric Disorder (PMDD) Players by Revenue (2017-2022) 3.1.2 Global Premenstrual Dysphoric Disorder (PMDD) Revenue Market Share by Players (2017-2022) 3.2 Global Premenstrual Dysphoric Disorder (PMDD) Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Premenstrual Dysphoric Disorder (PMDD) Revenue 3.4 Global Premenstrual Dysphoric Disorder (PMDD) Market Concentration Ratio 3.4.1 Global Premenstrual Dysphoric Disorder (PMDD) Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Premenstrual Dysphoric Disorder (PMDD) Revenue in 2021 3.5 Premenstrual Dysphoric Disorder (PMDD) Key Players Head office and Area Served 3.6 Key Players Premenstrual Dysphoric Disorder (PMDD) Product Solution and Service 3.7 Date of Enter into Premenstrual Dysphoric Disorder (PMDD) Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Premenstrual Dysphoric Disorder (PMDD) Breakdown Data by Type 4.1 Global Premenstrual Dysphoric Disorder (PMDD) Historic Market Size by Type (2017-2022) 4.2 Global Premenstrual Dysphoric Disorder (PMDD) Forecasted Market Size by Type (2023-2028) 5 Premenstrual Dysphoric Disorder (PMDD) Breakdown Data by Application 5.1 Global Premenstrual Dysphoric Disorder (PMDD) Historic Market Size by Application (2017-2022) 5.2 Global Premenstrual Dysphoric Disorder (PMDD) Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America Premenstrual Dysphoric Disorder (PMDD) Market Size (2017-2028) 6.2 North America Premenstrual Dysphoric Disorder (PMDD) Market Size by Type 6.2.1 North America Premenstrual Dysphoric Disorder (PMDD) Market Size by Type (2017-2022) 6.2.2 North America Premenstrual Dysphoric Disorder (PMDD) Market Size by Type (2023-2028) 6.2.3 North America Premenstrual Dysphoric Disorder (PMDD) Market Share by Type (2017-2028) 6.3 North America Premenstrual Dysphoric Disorder (PMDD) Market Size by Application 6.3.1 North America Premenstrual Dysphoric Disorder (PMDD) Market Size by Application (2017-2022) 6.3.2 North America Premenstrual Dysphoric Disorder (PMDD) Market Size by Application (2023-2028) 6.3.3 North America Premenstrual Dysphoric Disorder (PMDD) Market Share by Application (2017-2028) 6.4 North America Premenstrual Dysphoric Disorder (PMDD) Market Size by Country 6.4.1 North America Premenstrual Dysphoric Disorder (PMDD) Market Size by Country (2017-2022) 6.4.2 North America Premenstrual Dysphoric Disorder (PMDD) Market Size by Country (2023-2028) 6.4.3 U.S. 6.4.4 Canada 7 Europe 7.1 Europe Premenstrual Dysphoric Disorder (PMDD) Market Size (2017-2028) 7.2 Europe Premenstrual Dysphoric Disorder (PMDD) Market Size by Type 7.2.1 Europe Premenstrual Dysphoric Disorder (PMDD) Market Size by Type (2017-2022) 7.2.2 Europe Premenstrual Dysphoric Disorder (PMDD) Market Size by Type (2023-2028) 7.2.3 Europe Premenstrual Dysphoric Disorder (PMDD) Market Share by Type (2017-2028) 7.3 Europe Premenstrual Dysphoric Disorder (PMDD) Market Size by Application 7.3.1 Europe Premenstrual Dysphoric Disorder (PMDD) Market Size by Application (2017-2022) 7.3.2 Europe Premenstrual Dysphoric Disorder (PMDD) Market Size by Application (2023-2028) 7.3.3 Europe Premenstrual Dysphoric Disorder (PMDD) Market Share by Application (2017-2028) 7.4 Europe Premenstrual Dysphoric Disorder (PMDD) Market Size by Country 7.4.1 Europe Premenstrual Dysphoric Disorder (PMDD) Market Size by Country (2017-2022) 7.4.2 Europe Premenstrual Dysphoric Disorder (PMDD) Market Size by Country (2023-2028) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Premenstrual Dysphoric Disorder (PMDD) Market Size (2017-2028) 8.2 Asia-Pacific Premenstrual Dysphoric Disorder (PMDD) Market Size by Type 8.2.1 Asia-Pacific Premenstrual Dysphoric Disorder (PMDD) Market Size by Type (2017-2022) 8.2.2 Asia-Pacific Premenstrual Dysphoric Disorder (PMDD) Market Size by Type (2023-2028) 8.2.3 Asia-Pacific Premenstrual Dysphoric Disorder (PMDD) Market Share by Type (2017-2028) 8.3 Asia-Pacific Premenstrual Dysphoric Disorder (PMDD) Market Size by Application 8.3.1 Asia-Pacific Premenstrual Dysphoric Disorder (PMDD) Market Size by Application (2017-2022) 8.3.2 Asia-Pacific Premenstrual Dysphoric Disorder (PMDD) Market Size by Application (2023-2028) 8.3.3 Asia-Pacific Premenstrual Dysphoric Disorder (PMDD) Market Share by Application (2017-2028) 8.4 Asia-Pacific Premenstrual Dysphoric Disorder (PMDD) Market Size by Region 8.4.1 Asia-Pacific Premenstrual Dysphoric Disorder (PMDD) Market Size by Region (2017-2022) 8.4.2 Asia-Pacific Premenstrual Dysphoric Disorder (PMDD) Market Size by Region (2023-2028) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Premenstrual Dysphoric Disorder (PMDD) Market Size (2017-2028) 9.2 Latin America Premenstrual Dysphoric Disorder (PMDD) Market Size by Type 9.2.1 Latin America Premenstrual Dysphoric Disorder (PMDD) Market Size by Type (2017-2022) 9.2.2 Latin America Premenstrual Dysphoric Disorder (PMDD) Market Size by Type (2023-2028) 9.2.3 Latin America Premenstrual Dysphoric Disorder (PMDD) Market Share by Type (2017-2028) 9.3 Latin America Premenstrual Dysphoric Disorder (PMDD) Market Size by Application 9.3.1 Latin America Premenstrual Dysphoric Disorder (PMDD) Market Size by Application (2017-2022) 9.3.2 Latin America Premenstrual Dysphoric Disorder (PMDD) Market Size by Application (2023-2028) 9.3.3 Latin America Premenstrual Dysphoric Disorder (PMDD) Market Share by Application (2017-2028) 9.4 Latin America Premenstrual Dysphoric Disorder (PMDD) Market Size by Country 9.4.1 Latin America Premenstrual Dysphoric Disorder (PMDD) Market Size by Country (2017-2022) 9.4.2 Latin America Premenstrual Dysphoric Disorder (PMDD) Market Size by Country (2023-2028) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Premenstrual Dysphoric Disorder (PMDD) Market Size (2017-2028) 10.2 Middle East & Africa Premenstrual Dysphoric Disorder (PMDD) Market Size by Type 10.2.1 Middle East & Africa Premenstrual Dysphoric Disorder (PMDD) Market Size by Type (2017-2022) 10.2.2 Middle East & Africa Premenstrual Dysphoric Disorder (PMDD) Market Size by Type (2023-2028) 10.2.3 Middle East & Africa Premenstrual Dysphoric Disorder (PMDD) Market Share by Type (2017-2028) 10.3 Middle East & Africa Premenstrual Dysphoric Disorder (PMDD) Market Size by Application 10.3.1 Middle East & Africa Premenstrual Dysphoric Disorder (PMDD) Market Size by Application (2017-2022) 10.3.2 Middle East & Africa Premenstrual Dysphoric Disorder (PMDD) Market Size by Application (2023-2028) 10.3.3 Middle East & Africa Premenstrual Dysphoric Disorder (PMDD) Market Share by Application (2017-2028) 10.4 Middle East & Africa Premenstrual Dysphoric Disorder (PMDD) Market Size by Country 10.4.1 Middle East & Africa Premenstrual Dysphoric Disorder (PMDD) Market Size by Country (2017-2022) 10.4.2 Middle East & Africa Premenstrual Dysphoric Disorder (PMDD) Market Size by Country (2023-2028) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Teva 11.1.1 Teva Company Details 11.1.2 Teva Business Overview 11.1.3 Teva Premenstrual Dysphoric Disorder (PMDD) Introduction 11.1.4 Teva Revenue in Premenstrual Dysphoric Disorder (PMDD) Business (2017-2022) 11.1.5 Teva Recent Developments 11.2 Eli Liliy 11.2.1 Eli Liliy Company Details 11.2.2 Eli Liliy Business Overview 11.2.3 Eli Liliy Premenstrual Dysphoric Disorder (PMDD) Introduction 11.2.4 Eli Liliy Revenue in Premenstrual Dysphoric Disorder (PMDD) Business (2017-2022) 11.2.5 Eli Liliy Recent Developments 11.3 Pfizer 11.3.1 Pfizer Company Details 11.3.2 Pfizer Business Overview 11.3.3 Pfizer Premenstrual Dysphoric Disorder (PMDD) Introduction 11.3.4 Pfizer Revenue in Premenstrual Dysphoric Disorder (PMDD) Business (2017-2022) 11.3.5 Pfizer Recent Developments 11.4 Bayer 11.4.1 Bayer Company Details 11.4.2 Bayer Business Overview 11.4.3 Bayer Premenstrual Dysphoric Disorder (PMDD) Introduction 11.4.4 Bayer Revenue in Premenstrual Dysphoric Disorder (PMDD) Business (2017-2022) 11.4.5 Bayer Recent Developments 11.5 GSK 11.5.1 GSK Company Details 11.5.2 GSK Business Overview 11.5.3 GSK Premenstrual Dysphoric Disorder (PMDD) Introduction 11.5.4 GSK Revenue in Premenstrual Dysphoric Disorder (PMDD) Business (2017-2022) 11.5.5 GSK Recent Developments 11.6 Apotex 11.6.1 Apotex Company Details 11.6.2 Apotex Business Overview 11.6.3 Apotex Premenstrual Dysphoric Disorder (PMDD) Introduction 11.6.4 Apotex Revenue in Premenstrual Dysphoric Disorder (PMDD) Business (2017-2022) 11.6.5 Apotex Recent Developments 11.7 Bristol Laboratories 11.7.1 Bristol Laboratories Company Details 11.7.2 Bristol Laboratories Business Overview 11.7.3 Bristol Laboratories Premenstrual Dysphoric Disorder (PMDD) Introduction 11.7.4 Bristol Laboratories Revenue in Premenstrual Dysphoric Disorder (PMDD) Business (2017-2022) 11.7.5 Bristol Laboratories Recent Developments 11.8 Mylan 11.8.1 Mylan Company Details 11.8.2 Mylan Business Overview 11.8.3 Mylan Premenstrual Dysphoric Disorder (PMDD) Introduction 11.8.4 Mylan Revenue in Premenstrual Dysphoric Disorder (PMDD) Business (2017-2022) 11.8.5 Mylan Recent Developments 11.9 Allergan 11.9.1 Allergan Company Details 11.9.2 Allergan Business Overview 11.9.3 Allergan Premenstrual Dysphoric Disorder (PMDD) Introduction 11.9.4 Allergan Revenue in Premenstrual Dysphoric Disorder (PMDD) Business (2017-2022) 11.9.5 Allergan Recent Developments 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Author Details 13.3 Disclaimer

List of Tables Table 1. Global Premenstrual Dysphoric Disorder (PMDD) Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028 Table 2. Key Players of Table Product Table 3. Key Players of Inject Product Table 4. Key Players of Others Table 5. Global Premenstrual Dysphoric Disorder (PMDD) Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028 Table 6. Global Premenstrual Dysphoric Disorder (PMDD) Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 7. Global Premenstrual Dysphoric Disorder (PMDD) Market Size by Region (2017-2022) & (US$ Million) Table 8. Global Premenstrual Dysphoric Disorder (PMDD) Market Share by Region (2017-2022) Table 9. Global Premenstrual Dysphoric Disorder (PMDD) Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 10. Global Premenstrual Dysphoric Disorder (PMDD) Market Share by Region (2023-2028) Table 11. Premenstrual Dysphoric Disorder (PMDD) Market Trends Table 12. Premenstrual Dysphoric Disorder (PMDD) Market Drivers Table 13. Premenstrual Dysphoric Disorder (PMDD) Market Challenges Table 14. Premenstrual Dysphoric Disorder (PMDD) Market Restraints Table 15. Global Premenstrual Dysphoric Disorder (PMDD) Revenue by Players (2017-2022) & (US$ Million) Table 16. Global Premenstrual Dysphoric Disorder (PMDD) Revenue Share by Players (2017-2022) Table 17. Global Top Premenstrual Dysphoric Disorder (PMDD) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Premenstrual Dysphoric Disorder (PMDD) as of 2021) Table 18. Ranking of Global Top Premenstrual Dysphoric Disorder (PMDD) Companies by Revenue (US$ Million) in 2021 Table 19. Global 5 Largest Players Market Share by Premenstrual Dysphoric Disorder (PMDD) Revenue (CR5 and HHI) & (2017-2022) Table 20. Key Players Headquarters and Area Served Table 21. Key Players Premenstrual Dysphoric Disorder (PMDD) Product Solution and Service Table 22. Date of Enter into Premenstrual Dysphoric Disorder (PMDD) Market Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Global Premenstrual Dysphoric Disorder (PMDD) Market Size by Type (2017-2022) & (US$ Million) Table 25. Global Premenstrual Dysphoric Disorder (PMDD) Revenue Market Share by Type (2017-2022) Table 26. Global Premenstrual Dysphoric Disorder (PMDD) Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 27. Global Premenstrual Dysphoric Disorder (PMDD) Revenue Market Share by Type (2023-2028) Table 28. Global Premenstrual Dysphoric Disorder (PMDD) Market Size by Application (2017-2022) & (US$ Million) Table 29. Global Premenstrual Dysphoric Disorder (PMDD) Revenue Share by Application (2017-2022) Table 30. Global Premenstrual Dysphoric Disorder (PMDD) Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 31. Global Premenstrual Dysphoric Disorder (PMDD) Revenue Share by Application (2023-2028) Table 32. North America Premenstrual Dysphoric Disorder (PMDD) Market Size by Type (2017-2022) & (US$ Million) Table 33. North America Premenstrual Dysphoric Disorder (PMDD) Market Size by Type (2023-2028) & (US$ Million) Table 34. North America Premenstrual Dysphoric Disorder (PMDD) Market Size by Application (2017-2022) & (US$ Million) Table 35. North America Premenstrual Dysphoric Disorder (PMDD) Market Size by Application (2023-2028) & (US$ Million) Table 36. North America Premenstrual Dysphoric Disorder (PMDD) Market Size by Country (2017-2022) & (US$ Million) Table 37. North America Premenstrual Dysphoric Disorder (PMDD) Market Size by Country (2023-2028) & (US$ Million) Table 38. Europe Premenstrual Dysphoric Disorder (PMDD) Market Size by Type (2017-2022) & (US$ Million) Table 39. Europe Premenstrual Dysphoric Disorder (PMDD) Market Size by Type (2023-2028) & (US$ Million) Table 40. Europe Premenstrual Dysphoric Disorder (PMDD) Market Size by Application (2017-2022) & (US$ Million) Table 41. Europe Premenstrual Dysphoric Disorder (PMDD) Market Size by Application (2023-2028) & (US$ Million) Table 42. Europe Premenstrual Dysphoric Disorder (PMDD) Market Size by Country (2017-2022) & (US$ Million) Table 43. Europe Premenstrual Dysphoric Disorder (PMDD) Market Size by Country (2023-2028) & (US$ Million) Table 44. Asia Pacific Premenstrual Dysphoric Disorder (PMDD) Market Size by Type (2017-2022) & (US$ Million) Table 45. Asia Pacific Premenstrual Dysphoric Disorder (PMDD) Market Size by Type (2023-2028) & (US$ Million) Table 46. Asia Pacific Premenstrual Dysphoric Disorder (PMDD) Market Size by Application (2017-2022) & (US$ Million) Table 47. Asia Pacific Premenstrual Dysphoric Disorder (PMDD) Market Size by Application (2023-2028) & (US$ Million) Table 48. Asia Pacific Premenstrual Dysphoric Disorder (PMDD) Market Size by Region (2017-2022) & (US$ Million) Table 49. Asia Pacific Premenstrual Dysphoric Disorder (PMDD) Market Size by Region (2023-2028) & (US$ Million) Table 50. Latin America Premenstrual Dysphoric Disorder (PMDD) Market Size by Type (2017-2022) & (US$ Million) Table 51. Latin America Premenstrual Dysphoric Disorder (PMDD) Market Size by Type (2023-2028) & (US$ Million) Table 52. Latin America Premenstrual Dysphoric Disorder (PMDD) Market Size by Application (2017-2022) & (US$ Million) Table 53. Latin America Premenstrual Dysphoric Disorder (PMDD) Market Size by Application (2023-2028) & (US$ Million) Table 54. Latin America Premenstrual Dysphoric Disorder (PMDD) Market Size by Country (2017-2022) & (US$ Million) Table 55. Latin America Premenstrual Dysphoric Disorder (PMDD) Market Size by Country (2023-2028) & (US$ Million) Table 56. Middle East and Africa Premenstrual Dysphoric Disorder (PMDD) Market Size by Type (2017-2022) & (US$ Million) Table 57. Middle East and Africa Premenstrual Dysphoric Disorder (PMDD) Market Size by Type (2023-2028) & (US$ Million) Table 58. Middle East and Africa Premenstrual Dysphoric Disorder (PMDD) Market Size by Application (2017-2022) & (US$ Million) Table 59. Middle East and Africa Premenstrual Dysphoric Disorder (PMDD) Market Size by Application (2023-2028) & (US$ Million) Table 60. Middle East and Africa Premenstrual Dysphoric Disorder (PMDD) Market Size by Country (2017-2022) & (US$ Million) Table 61. Middle East and Africa Premenstrual Dysphoric Disorder (PMDD) Market Size by Country (2023-2028) & (US$ Million) Table 62. Teva Company Details Table 63. Teva Business Overview Table 64. Teva Premenstrual Dysphoric Disorder (PMDD) Product Table 65. Teva Revenue in Premenstrual Dysphoric Disorder (PMDD) Business (2017-2022) & (US$ Million) Table 66. Teva Recent Developments Table 67. Eli Liliy Company Details Table 68. Eli Liliy Business Overview Table 69. Eli Liliy Premenstrual Dysphoric Disorder (PMDD) Product Table 70. Eli Liliy Revenue in Premenstrual Dysphoric Disorder (PMDD) Business (2017-2022) & (US$ Million) Table 71. Eli Liliy Recent Developments Table 72. Pfizer Company Details Table 73. Pfizer Business Overview Table 74. Pfizer Premenstrual Dysphoric Disorder (PMDD) Product Table 75. Pfizer Revenue in Premenstrual Dysphoric Disorder (PMDD) Business (2017-2022) & (US$ Million) Table 76. Pfizer Recent Developments Table 77. Bayer Company Details Table 78. Bayer Business Overview Table 79. Bayer Premenstrual Dysphoric Disorder (PMDD) Product Table 80. Bayer Revenue in Premenstrual Dysphoric Disorder (PMDD) Business (2017-2022) & (US$ Million) Table 81. Bayer Recent Developments Table 82. GSK Company Details Table 83. GSK Business Overview Table 84. GSK Premenstrual Dysphoric Disorder (PMDD) Product Table 85. GSK Revenue in Premenstrual Dysphoric Disorder (PMDD) Business (2017-2022) & (US$ Million) Table 86. GSK Recent Developments Table 87. Apotex Company Details Table 88. Apotex Business Overview Table 89. Apotex Premenstrual Dysphoric Disorder (PMDD) Product Table 90. Apotex Revenue in Premenstrual Dysphoric Disorder (PMDD) Business (2017-2022) & (US$ Million) Table 91. Apotex Recent Developments Table 92. Bristol Laboratories Company Details Table 93. Bristol Laboratories Business Overview Table 94. Bristol Laboratories Premenstrual Dysphoric Disorder (PMDD) Product Table 95. Bristol Laboratories Revenue in Premenstrual Dysphoric Disorder (PMDD) Business (2017-2022) & (US$ Million) Table 96. Bristol Laboratories Recent Developments Table 97. Mylan Company Details Table 98. Mylan Business Overview Table 99. Mylan Premenstrual Dysphoric Disorder (PMDD) Product Table 100. Mylan Revenue in Premenstrual Dysphoric Disorder (PMDD) Business (2017-2022) & (US$ Million) Table 101. Mylan Recent Developments Table 102. Allergan Company Details Table 103. Allergan Business Overview Table 104. Allergan Premenstrual Dysphoric Disorder (PMDD) Product Table 105. Allergan Revenue in Premenstrual Dysphoric Disorder (PMDD) Business (2017-2022) & (US$ Million) Table 106. Allergan Recent Developments Table 107. Research Programs/Design for This Report Table 108. Key Data Information from Secondary Sources Table 109. Key Data Information from Primary Sources List of Figures Figure 1. Global Premenstrual Dysphoric Disorder (PMDD) Market Share by Type: 2021 VS 2028 Figure 2. Table Product Features Figure 3. Inject Product Features Figure 4. Others Features Figure 5. Global Premenstrual Dysphoric Disorder (PMDD) Market Share by Application: 2021 VS 2028 Figure 6. Hospital Case Studies Figure 7. Clinic Case Studies Figure 8. Others Case Studies Figure 9. Premenstrual Dysphoric Disorder (PMDD) Report Years Considered Figure 10. Global Premenstrual Dysphoric Disorder (PMDD) Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 11. Global Premenstrual Dysphoric Disorder (PMDD) Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 12. Global Premenstrual Dysphoric Disorder (PMDD) Market Share by Region: 2021 VS 2028 Figure 13. Global Premenstrual Dysphoric Disorder (PMDD) Market Share by Players in 2021 Figure 14. Global Top Premenstrual Dysphoric Disorder (PMDD) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Premenstrual Dysphoric Disorder (PMDD) as of 2021) Figure 15. The Top 10 and 5 Players Market Share by Premenstrual Dysphoric Disorder (PMDD) Revenue in 2021 Figure 16. North America Premenstrual Dysphoric Disorder (PMDD) Market Size YoY (2017-2028) & (US$ Million) Figure 17. North America Premenstrual Dysphoric Disorder (PMDD) Market Size Market Share by Type (2017-2028) Figure 18. North America Premenstrual Dysphoric Disorder (PMDD) Market Size Market Share by Application (2017-2028) Figure 19. North America Premenstrual Dysphoric Disorder (PMDD) Market Size Share by Country (2017-2028) Figure 20. United States Premenstrual Dysphoric Disorder (PMDD) Market Size YoY Growth (2017-2028) & (US$ Million) Figure 21. Canada Premenstrual Dysphoric Disorder (PMDD) Market Size YoY Growth (2017-2028) & (US$ Million) Figure 22. Europe Premenstrual Dysphoric Disorder (PMDD) Market Size YoY (2017-2028) & (US$ Million) Figure 23. Europe Premenstrual Dysphoric Disorder (PMDD) Market Size Market Share by Type (2017-2028) Figure 24. Europe Premenstrual Dysphoric Disorder (PMDD) Market Size Market Share by Application (2017-2028) Figure 25. Europe Premenstrual Dysphoric Disorder (PMDD) Market Size Share by Country (2017-2028) Figure 26. Germany Premenstrual Dysphoric Disorder (PMDD) Market Size YoY Growth (2017-2028) & (US$ Million) Figure 27. France Premenstrual Dysphoric Disorder (PMDD) Market Size YoY Growth (2017-2028) & (US$ Million) Figure 28. U.K. Premenstrual Dysphoric Disorder (PMDD) Market Size YoY Growth (2017-2028) & (US$ Million) Figure 29. Italy Premenstrual Dysphoric Disorder (PMDD) Market Size YoY Growth (2017-2028) & (US$ Million) Figure 30. Russia Premenstrual Dysphoric Disorder (PMDD) Market Size YoY Growth (2017-2028) & (US$ Million) Figure 31. Nordic Countries Premenstrual Dysphoric Disorder (PMDD) Market Size YoY Growth (2017-2028) & (US$ Million) Figure 32. Asia-Pacific Premenstrual Dysphoric Disorder (PMDD) Market Size YoY (2017-2028) & (US$ Million) Figure 33. Asia Pacific Premenstrual Dysphoric Disorder (PMDD) Market Size Market Share by Type (2017-2028) Figure 34. Asia Pacific Premenstrual Dysphoric Disorder (PMDD) Market Size Market Share by Application (2017-2028) Figure 35. Asia Pacific Premenstrual Dysphoric Disorder (PMDD) Market Size Share by Region (2017-2028) Figure 36. China Premenstrual Dysphoric Disorder (PMDD) Market Size YoY Growth (2017-2028) & (US$ Million) Figure 37. Japan Premenstrual Dysphoric Disorder (PMDD) Market Size YoY Growth (2017-2028) & (US$ Million) Figure 38. South Korea Premenstrual Dysphoric Disorder (PMDD) Market Size YoY Growth (2017-2028) & (US$ Million) Figure 39. Southeast Asia Premenstrual Dysphoric Disorder (PMDD) Market Size YoY Growth (2017-2028) & (US$ Million) Figure 40. India Premenstrual Dysphoric Disorder (PMDD) Market Size YoY Growth (2017-2028) & (US$ Million) Figure 41. Australia Premenstrual Dysphoric Disorder (PMDD) Market Size YoY Growth (2017-2028) & (US$ Million) List of Figures Figure 42. Latin America Premenstrual Dysphoric Disorder (PMDD) Market Size YoY (2017-2028) & (US$ Million) Figure 43. Latin America Premenstrual Dysphoric Disorder (PMDD) Market Size Market Share by Type (2017-2028) Figure 44. Latin America Premenstrual Dysphoric Disorder (PMDD) Market Size Market Share by Application (2017-2028) Figure 45. Latin America Premenstrual Dysphoric Disorder (PMDD) Market Size Share by Country (2017-2028) Figure 46. Mexico Premenstrual Dysphoric Disorder (PMDD) Market Size YoY Growth (2017-2028) & (US$ Million) Figure 47. Brazil Premenstrual Dysphoric Disorder (PMDD) Market Size YoY Growth (2017-2028) & (US$ Million) Figure 48. Middle East & Africa Premenstrual Dysphoric Disorder (PMDD) Market Size YoY (2017-2028) & (US$ Million) Figure 49. Middle East and Africa Premenstrual Dysphoric Disorder (PMDD) Market Size Market Share by Type (2017-2028) Figure 50. Middle East and Africa Premenstrual Dysphoric Disorder (PMDD) Market Size Market Share by Application (2017-2028) Figure 51. Middle East and Africa Premenstrual Dysphoric Disorder (PMDD) Market Size Share by Country (2017-2028) Figure 52. Turkey Premenstrual Dysphoric Disorder (PMDD) Market Size YoY Growth (2017-2028) & (US$ Million) Figure 53. Saudi Arabia Premenstrual Dysphoric Disorder (PMDD) Market Size YoY Growth (2017-2028) & (US$ Million) Figure 54. UAE Premenstrual Dysphoric Disorder (PMDD) Market Size YoY Growth (2017-2028) & (US$ Million) Figure 55. Teva Revenue Growth Rate in Premenstrual Dysphoric Disorder (PMDD) Business (2017-2022) Figure 56. Eli Liliy Revenue Growth Rate in Premenstrual Dysphoric Disorder (PMDD) Business (2017-2022) Figure 57. Pfizer Revenue Growth Rate in Premenstrual Dysphoric Disorder (PMDD) Business (2017-2022) Figure 58. Bayer Revenue Growth Rate in Premenstrual Dysphoric Disorder (PMDD) Business (2017-2022) Figure 59. GSK Revenue Growth Rate in Premenstrual Dysphoric Disorder (PMDD) Business (2017-2022) Figure 60. Apotex Revenue Growth Rate in Premenstrual Dysphoric Disorder (PMDD) Business (2017-2022) Figure 61. Bristol Laboratories Revenue Growth Rate in Premenstrual Dysphoric Disorder (PMDD) Business (2017-2022) Figure 62. Mylan Revenue Growth Rate in Premenstrual Dysphoric Disorder (PMDD) Business (2017-2022) Figure 63. Allergan Revenue Growth Rate in Premenstrual Dysphoric Disorder (PMDD) Business (2017-2022) Figure 64. Bottom-up and Top-down Approaches for This Report Figure 65. Data Triangulation Figure 66. Key Executives Interviewed

Teva Eli Liliy Pfizer Bayer GSK Apotex Bristol Laboratories Mylan Allergan